CalciMedica
CalciMedica is a clinical-stage biopharmaceutical company developing therapies for life-threatening inflammatory diseases with high unmet need.
/10
Transparency ranking
Work at CalciMedica?
Tell us what we're missing about working at CalciMedica so we can make the job search more transparent for everyone.
Tell us what it's like to work at CalciMedica!Description
CalciMedica is a clinical-stage biopharmaceutical company specializing in developing first-in-class therapies for life-threatening inflammatory diseases with high unmet need. Their focus is on CRAC (calcium release-activated calcium) channel inhibitors, a new class of therapies designed to modulate the immune response and protect against tissue cell injury. The company's lead candidate, Auxora™, is an intravenous formulation of a small molecule CRAC channel inhibitor currently in development for the treatment of acute pancreatitis (AP), asparaginase-induced pancreatic toxicity (AIPT), acute kidney injury (AKI), and acute respiratory distress syndrome (ARDS).
CalciMedica has a strong leadership team with extensive experience in the life sciences industry, drug development, and CRAC channel research. They are actively involved in clinical trials for Auxora™ across various inflammatory conditions, with promising early results demonstrating the potential for improved patient outcomes. The company is committed to addressing the significant unmet needs in these disease areas and bringing safe and effective therapies to market for patients in need.
Mission
CalciMedica is a clinical-stage biopharmaceutical company focused on developing innovative therapies to treat life-threatening inflammatory diseases with high unmet need. The company's proprietary technology targets the inhibition of CRAC channels, which are involved in regulating the immune response and protecting against tissue cell injury. CalciMedica's goal is to bring to market a new class of therapies that can effectively treat inflammatory diseases for which there are currently no approved disease-modifying treatments.
Culture
CalciMedica cultivates a collaborative and innovative culture centered around scientific advancement and a dedication to developing therapies for life-threatening inflammatory diseases. The company emphasizes a team-oriented approach, bringing together scientists, physicians, drug development experts, and entrepreneurs, all driven by a shared commitment to addressing critical unmet needs in the healthcare industry.
DE&I
CalciMedica's website does not provide any information regarding the company's approach to diversity, equity, and inclusion.
Similar companies. But verified.
